Marta Mosca
Impact in
- Rheumatology top 0.01%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
-
- Systemic Sclerosis and Related Diseases
Papers in
- Rheumatology 223
- Systemic Lupus Erythematosus Research 202
- Rheumatoid Arthritis Research and Therapies 21
-
- Systemic Sclerosis and Related Diseases 44
- Co-authors
- Stefano Bombardieri (80 shared papers)Chiara Tani (95 shared papers)Rossella Neri (22 shared papers)Chiara Baldini (55 shared papers)Linda Carli (42 shared papers)Rosaria Talarico (52 shared papers)Caroline Gordon (4 shared papers)Bridget Griffiths (1 shared paper)
- Journals
- Annals of the Rheumatic Diseases (50 papers)Lara D. Veeken (28 papers)Lupus Science & Medicine (20 papers)Lupus (19 papers)Clinical and Experimental Rheumatology (18 papers)
- Partner nations
- ItalyUnited KingdomGermany
In The Last Decade
Marta Mosca
386 papers receiving 21.8k citations
Marta Mosca's Hit Papers
Peers
Comparison fields: 5 of 139
- Rheumatology 14.3k
- Pathology and Forensic Medicine 1k
- Pulmonary and Respiratory Medicine 1.5k
- Immunology 828
- Hepatology 349
Countries citing papers authored by Marta Mosca
This map shows the geographic impact of Marta Mosca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Mosca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Mosca more than expected).
Fields of papers citing papers by Marta Mosca
This network shows the impact of papers produced by Marta Mosca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Mosca. The network helps show where Marta Mosca may publish in the future.
Co-authors
The 25 scholars most cited alongside Marta Mosca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 407 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus Hit paper breakdown → | 2019 | 1722 |
| 2 | Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients Hit paper breakdown → | 2002 | 1588 |
| 3 | 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus Hit paper breakdown → | 2019 | 1467 |
| 4 | 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus Hit paper breakdown → | 2019 | 1115 |
| 5 | EULAR recommendations for the management of antiphospholipid syndrome in adults Hit paper breakdown → | 2019 | 852 |
| 6 | An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features Hit paper breakdown → | 2015 | 809 |
| 7 | EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome Hit paper breakdown → | 2016 | 663 |
| 8 | 2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis Hit paper breakdown → | 2020 | 623 |
| 9 | EULAR recommendations for the management of systemic lupus erythematosus: 2023 update Hit paper breakdown → | 2023 | 612 |
| 10 | Treat-to-target in systemic lupus erythematosus: recommendations from an international task force Hit paper breakdown → | 2014 | 603 |
| 11 | Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial Hit paper breakdown → | 2018 | 415 |
| 12 | 1996 | 393 | |
| 13 | 2001 | 380 | |
| 14 | A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS) Hit paper breakdown → | 2016 | 309 |
| 15 | 2009 | 296 | |
| 16 | 2005 | 279 | |
| 17 | 2006 | 273 | |
| 18 | 2021 DORIS definition of remission in SLE: final recommendations from an international task force Hit paper breakdown → | 2021 | 271 |
| 19 | 2008 | 235 | |
| 20 | Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. | 1999 | 224 |
About Marta Mosca
Marta Mosca is a scholar working on Rheumatology, Pathology and Forensic Medicine, Ophthalmology, Physiology and Pulmonary and Respiratory Medicine, having authored 407 papers that have together received 22.5k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (202 papers), Systemic Sclerosis and Related Diseases (44 papers), Salivary Gland Disorders and Functions (25 papers), Ocular Diseases and Behçet’s Syndrome (25 papers), Rheumatoid Arthritis Research and Therapies (21 papers), Inflammatory Myopathies and Dermatomyositis (19 papers), Pregnancy and Medication Impact (15 papers) and Vasculitis and related conditions (11 papers). The work is most often cited by research in Rheumatology (14.3k citations), Pathology and Forensic Medicine (1k citations), Pulmonary and Respiratory Medicine (1.5k citations), Immunology (828 citations) and Hepatology (349 citations). Marta Mosca has collaborated with scholars based in Italy, United Kingdom and Germany. Frequent co-authors include Stefano Bombardieri, Chiara Tani, Rossella Neri, Chiara Baldini, Linda Carli, Rosaria Talarico, Caroline Gordon, Bridget Griffiths, Michelle Petri and Andrea. Schwartz Doria. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Lupus Science & Medicine, Lupus and Clinical and Experimental Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.